Autologous Matrix-induced Chondrogenesis Gaining Clinical Traction in Improving Long-Term Outcome

Autologous matrix-induced chondrogenesis has expanded the options for the treatment of cartilage defects, especially in osteochondral lesions of the knee and ankle joints. The new method typically combines autologous chondrocyte transplantation with matrix-associated chondrogenesis. Combining microfracturing with a collagen I/III matrix has opened a new clinical avenue for cartilage resurfacing. Strides made in cartilage resurfacing has made patients and care providers and givers skeptical of the long-term clinical results of a number of arthroscopic procedures. The evolutionary drive for the autologous matrix-induced chondrogenesis market stemmed from this.

Get Sample Copy of this Report @ 

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6150

Potential in Healing Cartilage Defects Spur Interest among Industry and Academia

Prevalence of bone and joint disorders is one of the key factors stimulating research and development investments in articular cartilage resurfacing. Despite advances made in microfracture technique, care providers have not been able to prevent the risk of severe osteoarthritis in patients with cartilage defects. A growing body of research has shown the efficacy of autologous matrix-induced chondrogenesis in accelerating cartilage healing and ensuring a homogeneous distribution of mesenchymal stem cells. The relentless search for novel reparative techniques for resurfacing articular cartilage defects has expanded avenues in the autologous matrix-induced chondrogenesis market.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6150

The growing severity of chondral lesions in aging populations has propelled advances in microfracture technique, boosting the demand for a method such as autologous matrix-induced chondrogenesis. Growing numbers of patients especially with cartilage defects of the knee who want to gain a pain-free joint as well as physiological range of motion have pinned hope on this new method, a key factor contributing to the growth of the autologous matrix-induced chondrogenesis market. The method is characterized by culture-free procedure and hence effective. Advances in arthroscopy technologies help improve the outcome of the method, thereby bolstering prospects of the market.

Author: Rohit Bhisey

As Head of Marketing at TMR Research, Rohit brings to the table over a decade of experience in market research and Internet marketing. His dedication, perseverance, and passion for perfection have enabled him to achieve immense success in his field. Rohit is an expert at formulating new business plans and strategies to help boost web traffic. His interests lie in writing news articles on technology,healthcare and business.

Leave a Reply